Calmodulin dependence of presynaptic metabotropic glutamate receptor signaling

Science

Volumn 286, Issue 5442, 1999, Pages 1180-1184

  O'Connor, Vincent ^a,d   El Oussama, Far ^a   Bofill Cardona, Elisa ^b   Nanoff, Christian ^b   Freissmuth, Michael ^b   Karschin, Andreas ^c   Airas, José M ^a   Betz, Heinrich ^a   Boehm, Stefan ^b  

^a MAX PLANCK INSTITUTE FOR BRAIN RESEARCH   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALMODULIN; GUANINE NUCLEOTIDE BINDING PROTEIN; METABOTROPIC RECEPTOR; PRESYNAPTIC RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; HIPPOCAMPUS; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM; CALMODULIN; CELLS, CULTURED; DIMERIZATION; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; GLUTAMIC ACID; GTP-BINDING PROTEINS; HIPPOCAMPUS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NEURONS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PRESYNAPTIC TERMINALS; PROPIONIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SWINE; SYNAPTIC TRANSMISSION; TERPENES;

ANIMALIA;

EID: 0033527687     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.286.5442.1180     Document Type: Article

References (41)

1. S. M. Thompson, M. Capogna, M. Scanziani, Trends Neurosci. 16, 222 (1993).
2. J.-P. Pin and J. Bockaert, Curt. Opin. Neurobiol. 5, 342 (1995); J.-P. Pin and R. Duvoisin, Neuropharmacology 34, 1 (1995).
3. J.-P. Pin and J. Bockaert, Curt. Opin. Neurobiol. 5, 342 (1995); J.-P. Pin and R. Duvoisin, Neuropharmacology 34, 1 (1995).
4. T. J. Bushell et al., Br. J. Pharmacol. 117, 1457 (1996);
5. T. Takahashi, I. D. Forsythe, T. Tsujimoto, M. Barnes-Davies, K. Onodera, Science 274, 594 (1996).
6. S. R. Ikeda, Nature 380, 255 (1996); 5. Herlitze et al., ibid., p. 258.
7. S. R. Ikeda, Nature 380, 255 (1996); S. Herlitze et al., ibid., p. 258.
8. R. Shigemoto et al., ibid. 381, 523 (1996); R. Shigemoto et al., J. Neurosci. 17, 7503 (1997).
9. R. Shigemoto et al., ibid. 381, 523 (1996); R. Shigemoto et al., J. Neurosci. 17, 7503 (1997).
10. J. A. Saugstad, J. M. Kinzie, M. M. Shinohara, T. P. Sergerson, G. L. Westbrook, Mol. Pharmacol. 51, 119 (1997).
11. To generate sequences encoding the COOH-terminal region of mGluR 7 [N. Okamoto et al., J. Biol. Chem. 269, 1231 (1994)], we used oligonucleotides complementary to the codons of amino acids 851 to 857 (HPELNVQ; gagattccaccctgaactcaatgtccag) and 910 to 916 (YNNLVIstop; ctgtcgacttagataaccaggttattata) in a standard PCR on mouse brain cDNA at annealing temperatures of 52°C (26). This generated two products corresponding to cDNAs encoding the known COOH-terminal region of mGluR 7 (mGluR 7A) and a recently reported splice variant [P. J. Flor et al., Neuropharmacology 36, 153 (1997)] containing an additional 81-base pair insertion (mGluR 7B). Full-length mGluR 7A-ΔCaM and truncated mGluR 7A tail sequences were also generated by PCR using a similar procedure. All amplification products were verified by automated DNA sequencing.
12. To generate sequences encoding the COOH-terminal region of mGluR 7 [N. Okamoto et al., J. Biol. Chem. 269, 1231 (1994)], we used oligonucleotides complementary to the codons of amino acids 851 to 857 (HPELNVQ; gagattccaccctgaactcaatgtccag) and 910 to 916 (YNNLVIstop; ctgtcgacttagataaccaggttattata) in a standard PCR on mouse brain cDNA at annealing temperatures of 52°C (26). This generated two products corresponding to cDNAs encoding the known COOH-terminal region of mGluR 7 (mGluR 7A) and a recently reported splice variant [P. J. Flor et al., Neuropharmacology 36, 153 (1997)] containing an additional 81-base pair insertion (mGluR 7B). Full-length mGluR 7A-ΔCaM and truncated mGluR 7A tail sequences were also generated by PCR using a similar procedure. All amplification products were verified by automated DNA sequencing.
13. 2 or EGTA. After repeated washing, the beads were eluted with SDS-PAGE sample buffer.
14. R. D. Hinrichsen, Biochim. Biophys. Acta 1155, 277 (1993).
15. R. Minkami, N. Jinnai, H. Sugiyama, J. Biol. Chem. 272, 20291 (1997).
16. Affinity measurements were done by fluorescence spectroscopy using dansylated calmodulin.
17. V. O'Connor, O. El Far, J. Airas, unpublished data.
18. P. James, T. Vorherr, E. Carafoli, Trends Biochem. Sci. 20, 38 (1995).
19. P. C. Leung, W. A. Taylor, J. H. Wang, C. L. Tipton, J. Biol. Chem. 259, 2742 (1984).
20. V. O'Connor, unpublished data.
21. 2+ did not affect the binding of Gβγ to GST-7A. After repeated washing, bound proteins were eluted with 30 mM glutathione or SDS sample buffer. Immunoblots were done with antiserum 7 (Gβ-common) or antiserum 11 (Gα-common) (29).
22. 2+ did not affect the binding of Gβγ to GST-7A. After repeated washing, bound proteins were eluted with 30 mM glutathione or SDS sample buffer. Immunoblots were done with antiserum 7 (Gβ-common) or antiserum 11 (Gα-common) (29).
23. 2+ did not affect the binding of Gβγ to GST-7A. After repeated washing, bound proteins were eluted with 30 mM glutathione or SDS sample buffer. Immunoblots were done with antiserum 7 (Gβ-common) or antiserum 11 (Gα-common) (29).
24. P. J. Conn and J. P. Pin, Annu. Rev. Phamacol. Toxicol. 37, 205 (1997).
25. M. Freissmuth, C. Nanoff, E. Bofill-Cardona, data not shown.
26. 2, 20 mM glucose, and 10 mM Hepes, adjusted to pH 7.4 with NaOH. Drug application was performed as described (20). Postsynaptic glutamate responses were elicited by the direct application of 100 μM glutamate.
27. S. Boehm and H. Betz, J. Neurosci. 17, 4066 (1997).
28. S. Boehm, data not shown.
29. S. R. Bradley, A. I. Levey, S. M. Hersch, P. J. Conn, J. Neurosci. 16, 2044 (1996).
30. N. K. Thomas, D. I. Jane, H. W. Tse, J. C. Watkins, Neuropharmacology 35, 637 (1996).
31. K. Gietzen, I. Sadorf, H. Bader, Biochem. J. 207, 541 (1982).
32. K. P. Scholz and R. J. Miller, Neuron 8, 1139 (1992).
33. Abbreviations for the amino acid residues are as follows: A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gln; R, Arg; S, Ser; T, Thr; V, Val; W, Trp; and Y, Tyr.
34. E. Wischmeyer et al., Mol. Cell. Neurosci. 9, 194 (1997).
35. O. El Far, unpublished data.
36. C. Nanoff, T. Mitterauer, F. Roka, M. Hohenegger, M. Freissmuth, Mol. Pharmacol. 48, 806 (1995).
37. P. F. Chapman, B. G. Frenguelli, A. Smith, C. M. Chen, A. J. Silva, Neuron 14, 591 (1995).
38. X. M. Xia et al., Nature 395, 503 (1998).
39. A. Lee et al., Nature 399, 155 (1999).
40. M. Scanziani, P. A. Salin, K. E. Vogt, R. C. Malenka, R. A. Nicoll, Nature 385, 630 (1997).
41. We thank R. Shigemoto for mGluR 7A antisera, S. Nakanishi for cDNA, A. Niehuis, A. Motejlek, and E. Wischmeyer for experimental assistance, and M. Baier and M. Reitz for secretarial help. Supported by Deutsche Forschungsgemeinschaft (H.B.), Fonds der Chemischen Industrie (H.B.), the Human Frontier Science Program Organization (HFSPO; H.B.), and the Austrian Science Foundation (S.B., M.F., and C.N.). O.E.F. was supported by a HFSPO postdoctoral fellowship, and E.B.C. by a grant from the European Community.